Bioresorbable Vascular Scaffold Market by Type (Metal, Polymer), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals) and Geography – Global Forecast to 2027
The global bioresorbable vascular scaffold market size is projected to reach ~USD 75 million by 2027 from ~USD 50 million in 2022, at a CAGR of 8.5% during the forecast period. The market is driven by factors such as rapidly increasing geriatric population and the risk of coronary artery diseases and peripheral artery diseases. On the other hand, product failures and withdrawals are expected to limit market growth to a certain extent in the coming years.
To know about the assumptions considered for the study, Request for Free Sample Report
“Coronary artery disease segment accounted for the largest market share”
Based on the type of application, the bioresorbable vascular scaffold market is segmented into coronary artery disease and peripheral artery disease. Coronary artery disease accounted for the largest market share in 2021. This can be attributed to the increasingly sedentary lifestyles and the subsequent increase in the prevalence of artery blockages across the globe.
“The hospitals accounted for the largest market share in the bioresorbable vascular scaffold market, by end-user, during the forecast period”
The bioresorbable vascular scaffold market is segmented into hospitals and others based on the end user. In 2021, hospitals accounted for a large market share due to the increasing prevalence of CAD and PAD, government support in the form of funds and grants, the increasing patient pool, and improving healthcare infrastructures.
“North America region accounted for the highest CAGR”
The global bioresorbable vascular scaffold market is divided into four regions: North America, Asia-Pacific, Europe, and Rest of the World. According to the regional analysis, the North America region is likely to retain a significant market share in 2021 and the future. The North America bioresorbable vascular scaffold market is being propelled by the rising regulatory approval and commercial launch in the U.S. and Canadian markets. The presence of an untapped market, coupled with the increasing demand for PCI procedures, is expected to further support the growth of this market during the forecast period.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, and the Rest of the World – 10%
To know about the assumptions considered for the study, download the pdf brochure
Lits of Companies Profiled in the Report:
- Abbott (US)
- Cook Medical (US)
- Boston Scientific Corporation (US)
- W. L. Gore & Associates (US)
- Medtronic (Ireland)
- C. R. Bard, Inc. (US)
- Meril Life Sciences (India)
- Maquet Holding B.V. & Co. Kg (Germany)
- Reva Medical, Inc. (US)
- Elixir Medical (US)
- Arterial Remodeling Technologies (France)
- Biotronik (Germany)<.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of Contents
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 GROWTH RATE ASSUMPTIONS
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing lifestyle disorders
5.2.1.2 Increased risk of CAD and PAD in the elderly
5.2.2 RESTRAINTS
5.2.2.1 Presence of substitutes
5.2.3 OPPORTUNITIES
5.2.3.1 Emeriging markets to offer high growth opportunities for the market players
5.2.3.2 Product pipeline
5.2.4 CHALLENGES
5.2.4.1 Product withdrawl and failures
5.2.4.2 Risk of complications
5.4 TRADE ANALYSIS
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS OF BIORESORBABLE VASCULAR SCAFFOLD MARKET
6 GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY TYPE (USD MILLION)
6.1 INTRODUCTION
6.2 METAL BIORESORBABLE VASCULAR SCAFFOLD
6.3 POLYMER BIORESORBABLE VASCULAR SCAFFOLD
7 GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CORONARY ARTERY DISEASE
7.3 PERIPHERAL ARTERY DISEASE
8 GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.3 OTHERS
9 GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
10.4 MARKET SHARE ANALYSIS
10.5 COMPANY EVALUATION QUADRANT
10.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2020)
10.7 COMPETITIVE BENCHMARKING
10.8 COMPETITIVE SCENARIO
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products and Services Offered, Recent Developments, MnM View, Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats)*
11.1.1 ABBOTT
11.1.2 COOK MEDICAL
11.1.3 BOSTON SCIENTIFIC CORPORATION
11.1.4 W. L. GORE & ASSOCIATES
11.1.5 MEDTRONIC
11.1.6 C. R. BARD, INC.
11.1.7 MERIL LIFE SCIENCES
11.1.8 MAQUET HOLDING B.V. & CO. KG
11.1.9 REVA MEDICAL, INC.
11.1.10 ELIXIR MEDICAL
11.1.11 ARTERIAL REMODELING TECHNOLOGIES
11.1.12 BIOTRONIK
*Details on Business Overview, Products and Services Offered, Recent Developments, MnM View, Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INDUSTRY INSIGHTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
Growth opportunities and latent adjacency in Bioresorbable Vascular Scaffold Market